Ifedayo Victor Ogungbe to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Ifedayo Victor Ogungbe has written about Dose-Response Relationship, Drug.
Connection Strength
0.694
-
Adeyinka OS, Metibemu DS, Hampton T, Ojobor JC, Crown O, Falode J, Barrera MD, Alem F, Narayanan A, Ogungbe IV. Broad-spectrum inhibitor of non-structural protein 2 protease shows therapeutic efficacy against Venezuelan equine encephalitis viral infection. Eur J Med Chem. 2026 Apr 15; 308:118696.
Score: 0.191
-
Metibemu DS, Adeyinka OS, Falode J, Hampton T, Crown O, Ojobor JC, Narayanan A, Julander J, Ogungbe IV. Inhibitor of the non-structural protein 2 protease shows promising efficacy in mouse models of chikungunya. Eur J Med Chem. 2024 Nov 15; 278:116808.
Score: 0.172
-
Zhang H, Collins J, Nyamwihura R, Crown O, Ajayi O, Ogungbe IV. Vinyl sulfone-based inhibitors of trypanosomal cysteine protease rhodesain with improved antitrypanosomal activities. Bioorg Med Chem Lett. 2020 07 15; 30(14):127217.
Score: 0.128
-
Zhang H, Collins J, Nyamwihura R, Ware S, Kaiser M, Ogungbe IV. Discovery of a quinoline-based phenyl sulfone derivative as an antitrypanosomal agent. Bioorg Med Chem Lett. 2018 05 15; 28(9):1647-1651.
Score: 0.110
-
McShan D, Kathman S, Lowe B, Xu Z, Zhan J, Statsyuk A, Ogungbe IV. Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain. Bioorg Med Chem Lett. 2015 Oct 15; 25(20):4509-12.
Score: 0.092